Literature DB >> 1268823

Vasoformative sarcomas arising from BALB/3T3 cells attached to solid substrates.

C W Boone, N Takeichi, M Paranjpe, R Gilden.   

Abstract

The BALB/3T3 mouse embryo cell line, noted for its marked postconfluence inhibition of proliferation, anchorage dependence, and high serum requirement, and frequently studied as a prototype nontumorigenic "fibroblast" line that is compared with tumorigenic sublines transformed with various agents, produced tumors within 2 to 3 months when an average of 3 X 10(4) cells were implanted s.c. attached to 1- X 5- X 10-mm polycarbonate platelets. Plastic platelets alone produced no tumors after 1 year of observation. The tumors, as well as others arising from implants of BALB/3T3 cells attached to 3-mm glass beads, were given the histological diagnosis of "vasoformative saroma" because the tumor cells frequently formed vascular channels. The vasoformative pattern and the results of specific staining for reticulin and collagen support the likelihood that BALB/3T3 cells originated from endothelial cells rather than from fibroblasts. That the tumors were derived from BALB/3T3 cells and not host cells was proved when tumors arising in BALB/c X C57BL/6 F1 hybrids were shown to be transplantable to BALB/c but not to C57BL/6 mice. The cultured tumor cells showed loss of both postconfluence inhibition of proliferation and anchorage dependence. Evidence of the induction of endogenous oncornaviruses was obtained in only one of four tumors tested. These tumors also exhibited tumor-unique transplantation rejection antigens. We conclude that BALB/3T3 cells are preneoplastic and give rise to different spontaneously transformed clones bearing unique tumor rejection antigens when implanted in vivo attached to a solid substrate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268823

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  In the interest of clearer communication.

Authors:  L Hayflick
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

Review 2.  Factors involved in the modulation of cell proliferation in vivo and in vitro: the role of fibroblast and epidermal growth factors in the proliferative response of mammalian cells.

Authors:  D Gospodarowicz; G Greenburg; H Bialecki; B R Zetter
Journal:  In Vitro       Date:  1978-01

Review 3.  Viruses and human cancers: a long road of discovery of molecular paradigms.

Authors:  Martyn K White; Joseph S Pagano; Kamel Khalili
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 4.  Fibroblast and epidermal growth factors: their uses in vivo and in vitro in studies on cell functions and cell transplantation.

Authors:  D Gospodarowicz
Journal:  Mol Cell Biochem       Date:  1979-05-21       Impact factor: 3.396

5.  Selection and characterization of bovine aortic endothelial cells.

Authors:  S M Schwartz
Journal:  In Vitro       Date:  1978-12

6.  Comparison of adhesive bond strength of different cell types in vitro.

Authors:  M C Labant; R D Fletcher
Journal:  In Vitro       Date:  1980-09

7.  Isolation and characterization of a tumor cell surface antigen from spontaneously transformed BALB/c mouse fibroblasts.

Authors:  A R Kamm; W J Grimes
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

8.  Temperature dependency for maintenance of transformation in mouse cells transformed by simian virus 40 tsA mutants.

Authors:  F J O'Neill; S Cohen; L Renzetti
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

9.  Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control.

Authors:  E J Stanbridge; J Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

10.  Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.

Authors:  D Gospodarowicz; J Moran; D Braun; C Birdwell
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.